These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4443705)

  • 21. Effects of oral delta9-tetrahydrocannabinol on operant reinforcement schedule performance in rats.
    Ferraro DP; Gluck JP
    Pharmacology; 1974; 11(2):65-9. PubMed ID: 4829291
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of estrogen and progesterone on serum and pituitary prolactin levels in ovariectomized rats.
    Chen CL; Meites J
    Endocrinology; 1970 Mar; 86(3):503-5. PubMed ID: 5410438
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacology of orally administered 9 -tetrahydrocannabinol.
    Perez-Reyes M; Lipton MA; Timmons MC; Wall ME; Brine DR; Davis KH
    Clin Pharmacol Ther; 1973; 14(1):48-55. PubMed ID: 4683071
    [No Abstract]   [Full Text] [Related]  

  • 24. Lack of tolerance to the bradycardic effect of delta 9-trans-tetrahydrocannabinol in rats.
    Kaymakçalan S; Sivil S
    Pharmacology; 1974; 12(4-5):290-5. PubMed ID: 4449891
    [No Abstract]   [Full Text] [Related]  

  • 25. Dissociation between behavioral effects and changes in metabolism of cerebral serotonin following 9 -tetrahydrocannabinol.
    Gallager DW; Sanders-Bush E; Sulser F
    Psychopharmacologia; 1972; 26(4):337-45. PubMed ID: 4638199
    [No Abstract]   [Full Text] [Related]  

  • 26. A study of teratological effects of intravenous, subcutaneous, and intragastric administration of delta9-tetrahydrocannabinol in mice.
    Joneja MG
    Toxicol Appl Pharmacol; 1976 Apr; 36(1):151-62. PubMed ID: 1273835
    [No Abstract]   [Full Text] [Related]  

  • 27. Tetrahydrocannabinol, sesame oil and biogenic amines: a preliminary report.
    Anton AH; Serrano A; Beyer RD; Lavappa KS
    Life Sci; 1974 May; 14(9):1741-6. PubMed ID: 4407739
    [No Abstract]   [Full Text] [Related]  

  • 28. Mouse-killing behavior (muricide) induced by delta 9-tetrahydrocannabinol in the rat.
    Ueki S; Fujiwara M; Ogawa N
    Physiol Behav; 1972 Oct; 9(4):585-7. PubMed ID: 4677621
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol.
    Perez-Reyes M; Timmons MC; Davis KH; Wall EM
    Experientia; 1973 Nov; 29(11):1368-9. PubMed ID: 4761242
    [No Abstract]   [Full Text] [Related]  

  • 30. Tetrahydrocannabinols and serum prolactin levels in man.
    Lemberger L; Crabtree R; Rowe H; Clemens J
    Life Sci; 1975 Apr; 16(8):1339-43. PubMed ID: 1094213
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of normal growth by chronic administration of delta-9-tetrahydrocannabinol.
    Manning FJ; McDonough JH; Elsmore TF; Saller C; Sodetz FJ
    Science; 1971 Oct; 174(4007):424-6. PubMed ID: 5111999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronopharmacology of delta9-tetrahydrocannabinol hypothermia in mice.
    Abel EL
    Experientia; 1973 Dec; 29(12):1528-9. PubMed ID: 4772055
    [No Abstract]   [Full Text] [Related]  

  • 33. Delta9-tetrahydrocannabinol: subcortical spike bursts and motor manifestations in a Fischer rat treated orally for 109 days.
    Stadnicki SW; Schaeppi U; Rosenkrantz H; Braude MC
    Life Sci; 1974 Feb; 14(3):463-72. PubMed ID: 4823985
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute effects of two tetrahydrocannabinols (delta9-THC and delta8-THC) on water intake in water deprived rats: implications for behavioral studies on marijuana compounds.
    Järbe TU; Henriksson BG
    Psychopharmacologia; 1973 Jun; 30(4):315-22. PubMed ID: 4722202
    [No Abstract]   [Full Text] [Related]  

  • 35. Results of radioimmunoassays of rat pituitary and serum prolactin after adrenalectomy and perphenazine treatment in rats.
    Ben-David M; Danon A; Benveniste R; Weller CP; Sulman FG
    J Endocrinol; 1971 Aug; 50(4):599-606. PubMed ID: 5564404
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential neurochemistry and temporal pattern in rats treated orally with delta9-tetrahydrocannabinol for periods up to six months.
    Luthra UL; Rosenkrantz H; Heyman IA; Braude MC
    Toxicol Appl Pharmacol; 1975 May; 32(2):418-31. PubMed ID: 1171540
    [No Abstract]   [Full Text] [Related]  

  • 37. Labor division of rats under the influence of prolonged administration of (-) 9 -trans-tetrahydrocannabinol.
    Masur J
    Pharmacology; 1973; 9(1):35-40. PubMed ID: 4708976
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of delta9-tetrahydrocannabinol on experimental hypertension in rats.
    Varma DR; Goldbaum D
    J Pharm Pharmacol; 1975 Oct; 27(10):790-1. PubMed ID: 241799
    [No Abstract]   [Full Text] [Related]  

  • 39. Delta 9-tetrahydrocannabinol: aversive effects in rat at high doses.
    Elsmore TF; Fletcher GV
    Science; 1972 Feb; 175(4024):911-2. PubMed ID: 5008609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of synthetic 9 -tetrahydrocannabinol on pregnancy and offspring in the rat.
    Borgen LA; Davis WM; Pace HB
    Toxicol Appl Pharmacol; 1971 Dec; 20(4):480-6. PubMed ID: 5143590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.